Gralise: payments to doctors
Payments that named Gralise as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $628K
- Providers
- 14,507
- Transactions
- 38,166
- Average per transaction
- $16
The per-transaction average — $16 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 14,507 providers the average total is $43, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Almatica Pharma LLC | $526,519 | 83.8% |
| Assertio Therapeutics, Inc. | $101,651 | 16.2% |